查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
傳染病治療市場，按治療方式、傳染病類型、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1408897

傳染病治療市場，按治療方式、傳染病類型、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Infectious Disease Therapeutics Market, By Mode of Treatment, By Infectious Type, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年傳染病治療市場規模為 680.34 億美元，2023 年至 2030 年CAGR為 8.2%。

傳染病治療市場-市場動態

預計感染性疾病病例數量的增加將推動市場的成長

傳染病病例數量增加，可能會推動對治療干預措施的需求。這可能是由於生活方式的改變、抗生素抗藥性、國際旅行和人口密度等因素造成的。傳染病的例子包括流感、麻疹、HIV、鏈球菌性咽喉炎、COVID-19 和沙門氏菌。雖然傳染病在全球普遍存在，但其盛行率各不相同。例如，在美國，每年大約每5個人中就有1人感染流感病毒，而確診的朊病毒病人數不到300。根據美國國家衛生中心的統計，大約有380萬人感染了流感病毒。急診室就診，以傳染病和寄生蟲病作為初步診斷。然而，生物技術和藥物研究的不斷進步為開發更有效、更有針對性的傳染病治療方法提供了機會。此外，經濟衰退和不確定性可能會對醫療保健預算和傳染病治療資金分配產生影響。

傳染病治療市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球傳染病治療市場在預測期內（2023-2030 年）每年將以 8.2% 左右的CAGR成長
  • 根據治療模式細分，預計藥物將在 2022 年顯示最大的市場佔有率
  • 根據感染類型細分，2022年細菌感染為主導類型
  • 從配銷通路細分來看，2022年醫院為主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

傳染病治療市場-細分分析：

  • 全球傳染病治療市場根據治療模式、傳染病類型、配銷通路和地區進行細分。
  • 根據治療方式，市場分為三類：疫苗和藥物。藥品領域在市場上佔據主導地位。許多全球衛生組織、政府和非政府組織積極致力於促進傳染病藥物的供應，特別是在這些疾病造成嚴重公共衛生障礙的地區。
  • 根據感染類型，市場分為兩類：病毒、寄生蟲、真菌、細菌和其他。細菌細分市場的主導地位在很大程度上影響著市場。細菌感染仍然是一個重大的公共衛生問題，特別是在發展中地區。全球衛生計劃與政府、非營利組織和製藥公司之間的合作夥伴關係共同努力，努力提高有效治療的可用性並減輕全球細菌感染的負擔。
  • 根據配銷通路，市場分為兩類：診所、醫院和其他。醫院細分市場佔據主導地位。該市場主要由醫院部門控制。醫院在傳染病的識別和治療中發揮著至關重要的作用。他們擁有診斷設施、實驗室和醫療專業人員團隊，他們合作確定感染的病原體並建議適當的治療措施。

傳染病治療市場 - 地理洞察

傳染病治療市場在地理上廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲等各地區。這些區域根據業務涉及的國家進一步分類。在成長方面，由於抗病毒藥物的日益普及以及美國有許多製造商的存在，預計北美將主導市場。美國是醫療保健和製藥領域的研發中心，在研發方面的大量投資導致了傳染病新治療藥物的發現。根據美國醫藥統計數據，2021年美國醫藥產業收入達5,500億美元，而美國人同年在藥品上的支出為5,769億美元。預計到2025年，美國的醫藥支出將在6,050億美元至6,350億美元之間。抗病毒藥物的開發在治療病毒感染方面發揮至關重要的作用，並有助於市場的整體成長。抗病毒藥物的流行反映了對抗病毒感染的研究和開發的持續努力。另一方面，歐洲是第二大市場成長地區，這主要是由於傳染病預防和診斷支出的增加。

傳染病治療市場-競爭格局：

每年，美國製藥業都會推出各種具有顯著醫療功效的新藥。然而，其中相當多的藥物價格昂貴，導致私營部門和聯邦政府的醫療費用不斷增加。為了進入市場，新興生物製藥公司（通常是新創公司或中型企業）推出了專門針對傳染病或利基領域的創新療法。相反，擁有完善研發能力的大型製藥公司在傳染病療法的進步和商業化方面競爭。這些公司擁有必要的資源來進行廣泛的臨床試驗並確保全球分銷。

最近的發展：

根據資料分析和諮詢公司GlobalData 的數據，輝瑞、吉利德和葛蘭素史克預計到2023 年將成為傳染病市場的領導者。儘管當年COVID-19 銷售額預計將下降64%，但該市場預計仍將成長每年以5.7% 的速度成長，到2029 年年銷售額將達到1500 億美元。儘管全球人口大部分接種了疫苗，而且世界衛生組織宣布這場流行病結束為全球衛生緊急事件，但預計仍將出現這種成長。

目錄

第1章：傳染病治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依治療方式分類的傳染病治療市場片段
    • 按傳染病類型分類的傳染病治療市場片段
    • 按配銷通路的傳染病治療市場片段
    • 按國家/地區分類的傳染病治療市場片段
    • 按地區分類的傳染病治療市場片段
  • 競爭洞察

第 3 章：傳染病治療主要市場趨勢

  • 傳染病治療市場促進因素
    • 市場促進因素的影響分析
  • 傳染病治療市場限制
    • 市場限制影響分析
  • 傳染病治療市場機會
  • 傳染病治療市場未來趨勢

第 4 章：傳染病治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：傳染病治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：傳染病治療市場格局

  • 2022 年傳染病治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：傳染病治療市場 - 依治療模式

  • 概述
    • 按治療方式分類的細分市場佔有率分析
    • 疫苗
    • 藥品

第 8 章：傳染病治療市場 - 依傳染病類型

  • 概述
    • 按傳染類型分類的細分市場佔有率分析
    • 病毒性的
    • 寄生
    • 真菌
    • 細菌
    • 其他

第 9 章：傳染病治療市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 診所
    • 醫院
    • 其他

第 10 章：傳染病治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美傳染病治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按治療方式）
    • 北美市場規模和預測（按感染類型）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲傳染病治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按治療方式）
    • 歐洲市場規模和預測（按感染類型）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區傳染病治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依治療方式）
    • 亞太地區市場規模和預測（按感染類型）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲傳染病治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按治療方式）
    • 拉丁美洲市場規模與預測（按感染類型）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲傳染病治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按治療方式）
    • 中東和非洲市場規模及預測（按感染類型）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 傳染病治療產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Novartis AG,
    • Gilead
    • GlaxoSmithKline plc
    • Janssen Pharmaceutical, Inc.
    • F. Hoffmann-La Roche Ltd.
    • BioCryst Pharmaceuticals Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim GmbH.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2061

REPORT HIGHLIGHT

Infectious Disease Therapeutics Market size was valued at USD 68,034 Million in 2022, expanding at a CAGR of 8.2% from 2023 to 2030.

Infectious disease therapeutics encompasses the management of illnesses caused by harmful microorganisms including bacteria, viruses, fungi, and parasites. The primary objective of infectious disease therapeutics is to eradicate or regulate the proliferation and transmission of these pathogens within the body. The prompt identification and efficient treatment of individuals affected by infectious diseases have been among the most significant advancements in the field of medicine in the last century. Presently, cardiovascular disease and cancer have become the leading causes of mortality in the United States. However, the absence of innovative compounds and vaccines for the treatment and prevention of infectious diseases reaching clinical proof of concept in recent decades has resulted in a global health crisis. The emergence of new and previously unknown infectious diseases poses a grave threat to human well-being and the worldwide economy, as exemplified by the ongoing SARS-CoV-2 outbreak. To counteract these risks, it is imperative to implement comprehensive containment strategies, including virus characterization, serological testing, research on therapeutic antibodies, and the development of vaccines utilizing optimized protein expression systems to combat the rapid evolution of pathogens.

Infectious Disease Therapeutics Market- Market Dynamics

Increasing number of cases suffering with infectious diseases is expected to drive the growth of market

There is an increase in the number of cases of infectious diseases, it can drive the demand for therapeutic interventions. This may be due to factors such as changes in lifestyle, antibiotic resistance, international travel, and population density. Examples of infectious diseases include the flu, measles, HIV, strep throat, COVID-19, and salmonella. While infectious diseases are widespread globally, their prevalence varies. For instance, in the United States, approximately 1 out of every 5 individuals gets infected with the influenza virus each year, whereas the number of diagnosed prion diseases is less than 300. According to the National Center for health statistics, there are approximately 3.8 million emergency department visits with infectious and parasitic diseases as the primary diagnosis. However, the continuous advancements in biotechnology and pharmaceutical research offer opportunities for the development of more effective and targeted therapeutics for infectious diseases. Additionally, economic downturns and uncertainties can have an impact on healthcare budgets and the allocation of funds toward infectious disease therapeutics.

Infectious Disease Therapeutics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Infectious Disease Therapeutics market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2023-2030)
  • Based on Mode of Treatment segmentation, Drugs was predicted to show maximum market share in the year 2022
  • Based on Infectious Type segmentation, Bacterial was the leading type in 2022
  • Based on Distribution Channel segmentation, Hospital was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Infectious Disease Therapeutics Market- Segmentation Analysis:

  • The Global Infectious Disease Therapeutics Market is segmented on the basis of Mode of Treatment, Infectious Type, Distribution Channel and Region.
  • The market is divided into three categories based on Mode of Treatment: Vaccines and Drugs. The drugs segment dominates the market. Numerous global health organizations, governments, and NGOs actively contribute to promoting the availability of drugs for infectious diseases, especially in regions where these diseases present substantial public health obstacles.
  • The market is divided into two categories based on Infectious Type: Viral, Parasitic, Fungal, Bacterial and Others. The dominance of the bacterial segment largely influences the market. Bacterial infections continue to pose a major public health concern, particularly in developing regions. Efforts from global health initiatives, in conjunction with partnerships between governments, non-profit organizations, and pharmaceutical companies, strive to enhance the availability of effective treatments and alleviate the global burden of bacterial infections.
  • The market is divided into two categories based on Distribution channel: Clinic, Hospitals and Others. Hospitals Segment dominates the market. The market is predominantly controlled by the Hospitals Segment. Hospitals play a vital role in the identification and treatment of infectious diseases. They possess diagnostic facilities, laboratories, and a team of medical professionals who collaborate to determine the causative agents of infections and recommend suitable therapeutic measures.

Infectious Disease Therapeutics Market- Geographical Insights

The Infectious Disease Therapeutics Market is geographically widespread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the nations involved in the business. In terms of growth, North America is expected to dominate the market due to the increasing prevalence of antiviral drugs and the presence of numerous manufacturers in the United States. The United States serves as a hub for research and development in the healthcare and pharmaceutical sectors, with substantial investments in R&D leading to the discovery of new therapeutic agents for infectious diseases. According to U.S. Pharmaceutical Statistics, the revenue generated by the U.S. pharmaceutical industry reached USD 550 billion in 2021, while Americans spent USD 576.9 billion on medicine during the same year. It is projected that the United States will spend between USD605 billion and USD635 billion on medicine by 2025. The development of antiviral medications plays a crucial role in treating viral infections and contributes to the overall growth of the market. The prevalence of antiviral drugs reflects the ongoing efforts in research and development to combat viral infections. Europe, on the other hand, is the second-largest region for market growth, primarily due to the rising expenditure on the prevention and diagnosis of infectious diseases.

Infectious Disease Therapeutics Market- Competitive Landscape:

Every year, the pharmaceutical industry in the United States introduces a variety of new drugs that offer significant medical benefits. However, a considerable number of these drugs are costly and contribute to the increasing healthcare expenses for both the private sector and the federal government. In order to enter the market, emerging biopharmaceutical companies, often startups or medium-sized enterprises, bring forth innovative therapeutics that specifically target infectious diseases or niche areas. Conversely, large pharmaceutical companies with well-established research and development capabilities compete in the advancement and commercialization of infectious disease therapeutics. These companies possess the necessary resources to conduct extensive clinical trials and ensure global distribution.

Recent Developments:

According to data analytics and consultancy GlobalData, Pfizer, Gilead, and GSK are expected to become the leading players in the infectious diseases market by 2023. Despite a projected 64% decrease in COVID-19 sales that year, the market is anticipated to grow at a rate of 5.7% annually, reaching $150 billion in annual sales by 2029. This growth is predicted despite the global population being largely vaccinated and the World Health Organization declaring an end to the pandemic as a global health emergency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET KEY PLAYERS

  • Pfizer Inc.
  • Novartis AG,
  • Gilead
  • GlaxoSmithKline plc
  • Janssen Pharmaceutical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • BioCryst Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH.
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY MODE OF TREATMENT

  • Vaccines
  • Drugs

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY INFECTIOUS TYPE

  • Viral
  • Parasitic
  • Fungal
  • Bacterial
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

  • Clinic
  • Hospitals
  • Others

GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Disease Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Disease Therapeutics Market Snippet by Mode of treatment
    • 2.1.2. Infectious Disease Therapeutics Market Snippet by Infectious Type
    • 2.1.3. Infectious Disease Therapeutics Market Snippet by Distribution channel
    • 2.1.4. Infectious Disease Therapeutics Market Snippet by Country
    • 2.1.5. Infectious Disease Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Disease Therapeutics Key Market Trends

  • 3.1. Infectious Disease Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Disease Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Disease Therapeutics Market Opportunities
  • 3.4. Infectious Disease Therapeutics Market Future Trends

4. Infectious Disease Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Disease Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Infectious Disease Therapeutics Market Landscape

  • 6.1. Infectious Disease Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Disease Therapeutics Market - By Mode of treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Mode of treatment, 2022 & 2030 (%)
    • 7.1.2. Vaccines
    • 7.1.3. Drugs

8. Infectious Disease Therapeutics Market - By Infectious Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Infectious Type, 2022 & 2030 (%)
    • 8.1.2. Viral
    • 8.1.3. Parasitic
    • 8.1.4. Fungal
    • 8.1.5. Bacterial
    • 8.1.6. Others

9. Infectious Disease Therapeutics Market - By Distribution channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution channel, 2022 & 2030 (%)
    • 9.1.2. Clinic
    • 9.1.3. Hospitals
    • 9.1.4. Others

10. Infectious Disease Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Infectious Disease Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Infectious Disease Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Infectious Disease Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Infectious Disease Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Infectious Disease Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Mode of treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Infectious Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Infectious Disease Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Novartis AG,
    • 11.2.3. Gilead
    • 11.2.4. GlaxoSmithKline plc
    • 11.2.5. Janssen Pharmaceutical, Inc.
    • 11.2.6. F. Hoffmann-La Roche Ltd.
    • 11.2.7. BioCryst Pharmaceuticals Inc.
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Boehringer Ingelheim GmbH.
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Infectious Disease Therapeutics Market: Mode of treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of treatment
  • TABLE Global Infectious Disease Therapeutics Market, by Mode of treatment 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Infectious Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Infectious Type
  • TABLE Global Infectious Disease Therapeutics Market, by Infectious Type 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Distribution channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution channel
  • TABLE Global Infectious Disease Therapeutics Market, by Distribution channel 2018-2030 (USD Million)
  • TABLE Infectious Disease Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Infectious Disease Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE North America Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Europe Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Latin America Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Mode of treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Infectious Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Infectious Disease Therapeutics Market, by Distribution channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Infectious Disease Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Mode of treatment segment market share analysis, 2022 & 2030
  • FIGURE Mode of treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Infectious Type segment market share analysis, 2022 & 2030
  • FIGURE Infectious Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Europe Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE India Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Infectious Disease Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Infectious Disease Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)